
eMurmur, operated by CSD Labs International Inc. and CSD Labs GmbH, is a medical technology company specializing in AI-powered digital auscultation for heart, lung, and bowel health. Their flagship product, the eMurmur platform, is an open, hardware-neutral software solution compatible with multiple digital stethoscope models and telehealth platforms, enabling healthcare providers to screen, monitor, diagnose, and consult with greater accuracy and efficiency. The platform is FDA cleared, CE marked, HIPAA and GDPR compliant, and ISO 13485:2016 certified. eMurmur's technology transforms traditional stethoscope use into objective, quantitative assessments, improving clinical outcomes and accessibility in various care settings including clinics, hospitals, and remote care. The company also offers educational apps in partnership with 3M Littmann to enhance auscultation training globally. eMurmur has established partnerships with leading stethoscope manufacturers and telehealth providers, and has received multiple awards and government grants, positioning it as a leader in advanced digital auscultation technology.

eMurmur, operated by CSD Labs International Inc. and CSD Labs GmbH, is a medical technology company specializing in AI-powered digital auscultation for heart, lung, and bowel health. Their flagship product, the eMurmur platform, is an open, hardware-neutral software solution compatible with multiple digital stethoscope models and telehealth platforms, enabling healthcare providers to screen, monitor, diagnose, and consult with greater accuracy and efficiency. The platform is FDA cleared, CE marked, HIPAA and GDPR compliant, and ISO 13485:2016 certified. eMurmur's technology transforms traditional stethoscope use into objective, quantitative assessments, improving clinical outcomes and accessibility in various care settings including clinics, hospitals, and remote care. The company also offers educational apps in partnership with 3M Littmann to enhance auscultation training globally. eMurmur has established partnerships with leading stethoscope manufacturers and telehealth providers, and has received multiple awards and government grants, positioning it as a leader in advanced digital auscultation technology.
What they do: AI-powered digital auscultation platform (eMurmur) for heart, lung, and bowel health
Regulatory / standards: FDA cleared, CE marked, HIPAA & GDPR compliant, ISO 13485:2016 certified
Founded / HQ: Founded in Graz, Austria (2013–2015); corporate entities in Canada and Austria; HQ listed in Ottawa, Canada
Funding mix: Angel investors and government grants (including reported €420k angel round and €210k Austrian grant)
Team size (reported): ~11 employees
Clinical auscultation, automated heart murmur detection, telehealth-enabled diagnostic workflows
2014
Medical technology (digital health / medtech)
210000.00
Austrian start-up grant of €210,000 reported to support early R&D and feasibility work
420000.00
Reported €420,000 raised from angel investors
Participation in accelerator/support programmes and non-equity assistance (e.g., Creative Destruction Lab; MaRS Investment Accelerator Fund) reported
“Angel investors and government grants”